Alcohol and marijuana: Effects on epilepsy and use by patients with epilepsy

Epilepsia

Volumn 42, Issue 10, 2001, Pages 1266-1272

  Gordon, Elisabeth ^a   Devinsky, Orrin ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

Alcohol; Epilepsy; Marijuana; Seizures

Indexed keywords

ALCOHOL; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CANNABINOID; CANNABIS; CARBAMAZEPINE; ETHOSUXIMIDE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ARTICLE; CANNABIS ADDICTION; DISEASE PREDISPOSITION; DRUG ALCOHOL INTERACTION; DRUG WITHDRAWAL; EPILEPSY; HUMAN; LONG TERM EXPOSURE; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEIZURE; SEIZURE THRESHOLD;

ALCOHOL DRINKING; ALCOHOL WITHDRAWAL SEIZURES; ANTICONVULSANTS; DRUG INTERACTIONS; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMANS; MARIJUANA SMOKING; RISK FACTORS;

EID: 0035168639     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2001.19301.x     Document Type: Article

References (67)

1. The factors of insanities
2. Ethanol potentiation of GABAergic transmission in cultured spinal cord neurons involves gammaaminobutyric acid-gated chloride channels
3. Ethanol actions on multiple ion channels: Which are important?
4. The action of barbituates upon liver alcohol dehydrogenase: Their interference with alcohol metabolism
5. Effects of phenobarbital administration on rates of ethanol clearance and on ethanol-oxidizing enzymes in man
6. Alcohol related seizures, part II: Clinical presentation and management
7. Management of alcohol withdrawal syndromes
8. Alcoholic epilepsy: A unified and dynamic classification
9. The effect of various patterns of alcohol use on seizures in patients with epilepsy
10. Effects of single and repeated alcohol withdrawal on kindling
11. Myoclonic alcoholic epilepsy
12. Late-onset seizures in alcohol withdrawal
13. Juvenile myoclonic epilepsy: Clinical and EEG features
14. Status epilepticus: Causes, clinical features and consequences in 98 patients
15. Survival after high blood alcohol levels
16. Chronopharmacokinetics of ethanol II: Circadian rhythm in rates of blood level decline in a single subject
17. A controlled trial of fructose in the treatment of acute alcoholic intoxication
18. Interaction of phenobarbitone and ethanol studied from the dose-response curves and drug concentrations in blood
19. Interaction of ethanol with other drugs
20. Acetaldehyde adducts with serum proteins: Effect on diazepam and phenytoin binding
21. Acetaldehyde adducts with serum proteins are not responsible for decreased drug binding in alcoholics
22. Increased rate of clearance of drugs from the circulation of alcoholics
23. Drug metabolism in heavy consumers of ethyl alcohol
24. Interaction of ethanol with drug toxicity
25. Effect of short and long-term alcohol use on phenytoin kinetics in chronic alcoholics
26. Plasma protein binding of diphenylhydantoin: Effects of sex hormones renal and hepatic disease
27. Effects of route of administration and blood flow on hepatic drug elimination
28. Variable free and total valproic acid concentrations in sole and multidrug treatment
29. Head injuries due to falls caused by seizures: A group at high risk for traumatic intracranial hematomas
30. Electrical amygdala kindling in alcohol-withdrawal kindled rats
31. The glutamatergic basis of human alcoholism
32. Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal
33. Epilepsy and alcohol: The influence of social alcohol intake on seizures and treatment in epilepsy
34. Alcohol, seizures, and epilepsy
35. Constituents of Cannabis sativa L. XVII: A review of the natural constituents
36. Health aspects of cannabis
37. Therapeutic potential of cannabinoids in neurological disorders
38. Acute marijuana effects on rCBF and cognition: A PET study
39. The 94-day cannabis study
40. Effects of habitual use of marijuana and/or cocaine on the lung
41. Pharmacology and effects of cannabis: A brief review
42. Investigating the neurocognitive deficits associated with chronic drug misuse
43. A review of the usefulness of the standard EEG in psychiatry
44. Clinical relevance of cannabis tolerance and dependence
45. Molecular neurobiology of the cannabinoid receptor
46. Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker
47. The central neuropharmacology of psychotropic cannabinoids
48. Marihuana and epilepsy: Paradoxical anticonvulsant and convulsant effects
49. Interaction between delta9-tetrahydrocannibinol and kindling by electrical and chemical stimuli in mice
50. The influence of cannabidiol and delta-9-tetrahydrocannabinol on cobalt epilepsy in rats
51. Prolonged CNS hyperexcitability in mice after a single exposure to delta-9-tetrahydrocannabinol
52. The cannabinoids as potential antiepileptics
53. Effect of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice
54. Potential role of cannabinoids for therapy of neurological disorders
55. Towards drugs derived from cannabis
56. Chronic administration of cannabidiol to healthy volunteers and epileptic patients
57. Double-blind clinical study of cannabidiol as a secondary anticonvulsant
58. Anticonvulsant effect of cannabidiol
59. Illicit drug use and the risk of new-onset seizures
60. Anticonvulsant nature of marihuana smoking
61. Complex partial seizure symptoms affected by marijuana abuse, Clin Psychiatry
62. Grand mal convulsions subsequent to marijuana use
63. Stymied by seizures: When the clues point to the wrong path